Showing results (161-170 of 1,072) with videos related to
Sort By:
Pageof 108
JACC. Cardiovascular Interventions|April 9, 2016
Radial Access Reduces Mortality in Patients With Acute Coronary Syndromes: Results From an Updated Trial Sequential Analysis of Randomized TrialsGiuseppe Andò, Davide CapodannoMinerva Cardioangiologica|March 3, 2016
Long-term antithrombotic pharmacotherapy following ST-elevation myocardial infarctionSergio Buccheri, Davide CapodannoAmerican Heart Journal|May 5, 2024
Gender equality in medical research: A cardiology-informed examinationMarco Spagnolo, Davide CapodannoThrombosis and Haemostasis|June 24, 2026
Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?Riccardo Prezzavento, Davide CapodannoJournal of Cardiovascular Development and Disease|September 26, 2025
Personalized Treatment of Patients with Coronary Artery Disease: The Value and Limitations of Predictive ModelsAntonio Greco, Davide CapodannoExpert Review of Cardiovascular Therapy|March 12, 2021
Differences in coronary artery disease and outcomes of percutaneous coronary intervention with drug-eluting stents in women and menAntonio Greco, Davide CapodannoEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|March 3, 2021
Acute coronary syndrome with spontaneous coronary artery dissection: which therapeutic option for a different pathophysiology?Dario Calderone, Davide CapodannoInternational Journal of Cardiology|February 15, 2012
Does the SYNTAX score get on your nerves? Practical considerations on how and when avoiding it to maximize its usefulness with no waste of timeDavide Capodanno, Corrado TamburinoRecent Patents on Drug Delivery & Formulation|November 27, 2009
Properties and clinical development of a novel coating technology: the poly[bis(trifluoroethoxy)phosphazene]Davide Capodanno, Corrado TamburinoVascular Pharmacology|March 17, 2019
Switching between P2Y<sub>12</sub> inhibitors: Rationale, methods, and expected consequencesPiera Capranzano, Davide CapodannoPageof 108